Search research articles
Contact Us
Filters
Showing results (21-30 of 57) with videos related to
Page
of 6
Sort By:
BMC Cancer
|
February 5, 2021
Targeted RNAseq assay incorporating unique molecular identifiers for improved quantification of gene expression signatures and transcribed mutation fraction in fixed tumor samples
Chunxiao Fu, Michal Marczyk, Michael Samuels, et al.
Virchows Archiv : an International Journal of Pathology
|
November 14, 2009
Vascular endothelial growth factor C mRNA expression is a prognostic factor in epithelial ovarian cancer as detected by kinetic RT-PCR in formalin-fixed paraffin-embedded tissue
Bruno V Sinn, Silvia Darb-Esfahani, Ralph M Wirtz, et al.
Pancreas
|
April 1, 2014
KRAS mutations in codon 12 or 13 are associated with worse prognosis in pancreatic ductal adenocarcinoma
Bruno V Sinn, Jana K Striefler, Marc A Rudl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 25, 2014
SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 study
M Sinn, B V Sinn, J K Striefler, et al.
Endocrine-Related Cancer
|
August 14, 2009
Estrogen receptor 1 mRNA is a prognostic factor in ovarian carcinoma: determination by kinetic PCR in formalin-fixed paraffin-embedded tissue
Silvia Darb-Esfahani, Ralph M Wirtz, Bruno V Sinn, et al.
Journal of the American Society of Cytopathology
|
December 12, 2024
Comparative analysis of Ficoll-Hypaque and CytoLyt techniques for blood removal in breast cancer malignant effusions: effects on RNA quality and sequencing outcomes
Gloria H Sura, Kevin Tran, Alexander J Trevarton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2020
<i>TP53</i> Mutations Predict Sensitivity to Adjuvant Gemcitabine in Patients with Pancreatic Ductal Adenocarcinoma: Next-Generation Sequencing Results from the CONKO-001 Trial
Marianne Sinn, Bruno V Sinn, Denise Treue, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 11, 2013
Evaluation of Mucin-1 protein and mRNA expression as prognostic and predictive markers after neoadjuvant chemotherapy for breast cancer
B V Sinn, G von Minckwitz, C Denkert, et al.
Breast Cancer Research : BCR
|
February 9, 2013
HER2 and ESR1 mRNA expression levels and response to neoadjuvant trastuzumab plus chemotherapy in patients with primary breast cancer
Carsten Denkert, Jens Huober, Sibylle Loibl, et al.
Clinical Epigenetics
|
October 4, 2021
DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification status
Philipp Jurmeister, Karsten Weber, Sonia Villegas, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 57) with videos related to
Sort By:
Page
of 6
BMC Cancer
|
February 5, 2021
Targeted RNAseq assay incorporating unique molecular identifiers for improved quantification of gene expression signatures and transcribed mutation fraction in fixed tumor samples
Chunxiao Fu, Michal Marczyk, Michael Samuels, et al.
Virchows Archiv : an International Journal of Pathology
|
November 14, 2009
Vascular endothelial growth factor C mRNA expression is a prognostic factor in epithelial ovarian cancer as detected by kinetic RT-PCR in formalin-fixed paraffin-embedded tissue
Bruno V Sinn, Silvia Darb-Esfahani, Ralph M Wirtz, et al.
Pancreas
|
April 1, 2014
KRAS mutations in codon 12 or 13 are associated with worse prognosis in pancreatic ductal adenocarcinoma
Bruno V Sinn, Jana K Striefler, Marc A Rudl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 25, 2014
SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 study
M Sinn, B V Sinn, J K Striefler, et al.
Endocrine-Related Cancer
|
August 14, 2009
Estrogen receptor 1 mRNA is a prognostic factor in ovarian carcinoma: determination by kinetic PCR in formalin-fixed paraffin-embedded tissue
Silvia Darb-Esfahani, Ralph M Wirtz, Bruno V Sinn, et al.
Journal of the American Society of Cytopathology
|
December 12, 2024
Comparative analysis of Ficoll-Hypaque and CytoLyt techniques for blood removal in breast cancer malignant effusions: effects on RNA quality and sequencing outcomes
Gloria H Sura, Kevin Tran, Alexander J Trevarton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2020
<i>TP53</i> Mutations Predict Sensitivity to Adjuvant Gemcitabine in Patients with Pancreatic Ductal Adenocarcinoma: Next-Generation Sequencing Results from the CONKO-001 Trial
Marianne Sinn, Bruno V Sinn, Denise Treue, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 11, 2013
Evaluation of Mucin-1 protein and mRNA expression as prognostic and predictive markers after neoadjuvant chemotherapy for breast cancer
B V Sinn, G von Minckwitz, C Denkert, et al.
Breast Cancer Research : BCR
|
February 9, 2013
HER2 and ESR1 mRNA expression levels and response to neoadjuvant trastuzumab plus chemotherapy in patients with primary breast cancer
Carsten Denkert, Jens Huober, Sibylle Loibl, et al.
Clinical Epigenetics
|
October 4, 2021
DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification status
Philipp Jurmeister, Karsten Weber, Sonia Villegas, et al.
Page
of 6